|
|
|
|
| LEADER |
00890nam a22002412 4500 |
| 001 |
ebs53686688e |
| 003 |
EBZ |
| 006 |
m d |||||| |
| 007 |
cr|unu|||||||| |
| 008 |
200707nuuuuuuuuxx |||| s|||||||||||eng|d |
| 035 |
|
|
|a (EBZ)ebs53686688e
|
| 040 |
|
|
|a EBZ
|
| 042 |
|
|
|a msc
|
| 050 |
0 |
0 |
|a TP
|
| 130 |
0 |
|
|a Biosimilars Case Study (Sandoz, Neose Technology & SciGen): Exploiting Opportunities in Biosimilars (Online)
|
| 245 |
0 |
0 |
|a Biosimilars Case Study (Sandoz, Neose Technology & SciGen): Exploiting Opportunities in Biosimilars
|h [electronic resource].
|
| 260 |
|
|
|b Marketline
|c 2008
|
| 650 |
0 |
7 |
|a Biotechnology
|2 EBSCO-TLI
|
| 773 |
0 |
|
|t Business Source Complete
|d EBSCO
|
| 856 |
4 |
0 |
|3 Full text available: Jan 2008.
|z Available in Business Source Complete.
|u https://search.ebscohost.com/direct.asp?db=bth&jid=%225DBX%22&scope=site
|
| 999 |
|
|
|c 95502
|d 95502
|
| 942 |
|
|
|z EBS
|
| 942 |
|
|
|c REL
|